Bionik Laboratories (Bionik Laboratories) EV-to-Revenue : 1.79 (As of Apr. 28, 2024)

Bionik Laboratories EV-to-Revenue Chart

Bionik Laboratories Annual Data
	Trend	Dec14	Dec15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-Revenue		Get a 7-Day Free Trial					4.66	4.22	14.32	0.43	2.62

Bionik Laboratories Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-Revenue	Get a 7-Day Free Trial															0.43	7.03	2.43	3.61	2.62

Competitive Comparison of Bionik Laboratories's EV-to-Revenue

For the Medical Care Facilities subindustry, Bionik Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionik Laboratories's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's EV-to-Revenue falls into.

Bionik Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bionik Laboratories's EV-to-Revenue for today is calculated as:

Bionik Laboratories's current Enterprise Value is $3.23 Mil.
Bionik Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories  (OTCPK:BNKL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bionik Laboratories's PS Ratiofor today is calculated as:

Bionik Laboratories's share price for today is $0.10.
Bionik Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bionik Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionik Laboratories (Bionik Laboratories) Business Description